chr16-8847806-G-C

Variant summary

Our verdict is Uncertain significance.
+3 Uncertain · Warm
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 3 classification points (ACGS-UK Somatic Oncogenicity v2025). O6_SupportingO7_SupportingO8_Supporting

The NM_000303.3(PMM2):c.722G>C (p.Cys241Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The gene PMM2 is a cancer driver gene (CancerMine: 2 driver citations). The variant allele was found at a cumulative frequency of 0.0000645 (AC=104) in the gnomAD database across 1,613,056 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000582. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 8.25). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000633728: Experimental studies have shown that this missense change affects PMM2 function (PMID:11715002, 21541725, 22012410, 26014514)." and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.C241R: Likely_pathogenic (ClinVar VariationId 2847057, 1 star) This exact variant is curated in the UniProt human variants database as Uncertain Significance.

Frequency

Genomes: 𝑓 0.00024 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000046 ( 0 hom. )

Consequence

PMM2
NM_000303.3 missense

Scores

12
5
2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:23O:1

Conservation

PhyloP100: 8.25

Publications

33 publications found
Variant links:
Genes affected
PMM2 (HGNC:9115): (phosphomannomutase 2) The protein encoded by this gene catalyzes the isomerization of mannose 6-phosphate to mannose 1-phosphate, which is a precursor to GDP-mannose necessary for the synthesis of dolichol-P-oligosaccharides. Mutations in this gene have been shown to cause defects in glycoprotein biosynthesis, which manifests as carbohydrate-deficient glycoprotein syndrome type I. [provided by RefSeq, Jul 2008]
PMM2 Gene-Disease associations (from GenCC):
  • congenital disorder of glycosylation type I
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women's Health
  • PMM2-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Natera, PanelApp Australia, Orphanet, ClinGen
  • hyperinsulinemic hypoglycemia with polycystic kidney disease
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000303.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 3 points.

O6Computational evidence supports deleterious effect
Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect
O7Mutational hotspot or critical domain
Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 8 pathogenic, 1 benign (OR vs. background: 28.3); Variant does not impact splicing — splice-hotspot path not applicable
O8Missense constraint in gene or region
Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: -1.80 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000303.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

PMM2 NM_000303.3
MANE Select
HGVSc / HGVSpc.722G>Cp.Cys241Ser
Exon rankExon 8 of 8
missense
Prot: NP_000294.1UniProt: O15305-1A0A0S2Z4J6

Ensembl Transcripts

PMM2 ENST00000268261.9
TSL:1MANE Select
HGVSc / HGVSpc.722G>Cp.Cys241Ser
Exon rankExon 8 of 8
missense
Prot: ENSP00000268261.4UniProt: O15305-1
PMM2 ENST00000565221.5
TSL:1
HGVSc / HGVSpn.*340G>C
Exon rankExon 6 of 6
3_prime_UTR
Prot: ENSP00000457932.1UniProt: H3BV34
PMM2 ENST00000566540.5
TSL:1
HGVSc / HGVSpn.*344G>C
Exon rankExon 6 of 6
3_prime_UTR
Prot: ENSP00000454284.1UniProt: H3BM92

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.000243
AC:37
Hom:0
AN:152224
Cov:33
GnomAD2 exomes
AF: 0.0000598
AC:15
AN:250796
GnomAD4 exome
AF: 0.0000459
AC:67
Hom:0
AN:1460832
Cov:30
GnomAD4 genome
AF: 0.000243
AC:37
Hom:0
AN:152224
Cov:33
TOPMed (Bravo)
AF: 0.000212
AC:56
Hom:1
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.000279
AC:8
Hom:0
AN:28638
Showing 6 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
BipEx
(Bipolar disorder (including schizoaffective))
0.0000352 128420 0.00 028844
Epi25
(Epilepsy)
0.0000477 241958 0.000105 766878
SCHEMA
(Schizophrenia)
0.0000798 9112744 0.0000474 9190044
Showing 3 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
12
-
-
PMM2-congenital disorder of glycosylation (13)
9
-
-
not provided (9)
1
-
-
Inborn genetic diseases (1)
1
-
-
PMM2-related disorder (1)

Computational Scores

AlphaGenome AVI
Pathogenic26
AlphaMissense
Pathogenic0.74
BayesDel_addAF
Pathogenic0.30D
BayesDel_noAF
Pathogenic0.55
CADD
Uncertain25
DANN
Uncertain0.99
DEOGEN2
Pathogenic0.91D
Eigen
Pathogenic0.75
Eigen_PC
Uncertain0.66
FATHMM_MKL
Pathogenic0.99D
GPN-Star LLR
N/A-5.6
GPN-Star score
N/A5.6
LIST_S2
Uncertain0.93D
M_CAP
Pathogenic0.36D
MetaRNN
Pathogenic0.90D
MetaSVM
Pathogenic1.1D
Mutation Taster
N/A3/97disease causing (ClinVar)
MutationAssessor
Pathogenic3.1M
PhyloP100
Pathogenic8.3
popEVE
Benign-3.0
PrimateAI
Uncertain0.68T
PROVEAN
Uncertain-3.0D
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.1
REVEL
Pathogenic0.93
Sift
Benign0.042D
Sift4G
Benign0.21T
Varity_R
N/A0.94
VESM-3B
Benign-8.8
Showing 29 of 29 scores

Splicing Scores

Pangolin (max)
Benign0.010
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.